Status:
COMPLETED
Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis
Lead Sponsor:
National Defense Medical Center, Taiwan
Conditions:
Bladder Pain Syndrome
Interstitial Cystitis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The pathogenesis of bladder pain syndrome/interstitial cystitis (BPS/IC) is currently unclear. Scholars have put forward different hypotheses, including the function of the extracellular matrix surfac...
Detailed Description
This project treated 29 male and female subjects (aged over 20 years) with BPS/IC and other chronic inflammation of the bladder. The enrolled subjects were collected from May 2019 to October 2020. The...
Eligibility Criteria
Inclusion
- The subject is aged over 20 years old.
- The subject was diagnosed as bladder pain syndrome/interstitial cystitis subject with lower urinary tract symptoms, such as frequent urination, urgent urination, bladder pain, etc.
Exclusion
- The subject is aged under 20 years old.
- Pregnant women.
- The subject with congenital disorders of the urinary tract.
- The subject with a urinary tract infection or tumor.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2020
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04821882
Start Date
May 1 2019
End Date
October 11 2020
Last Update
April 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Defense of Medical Center, Tri-Service General Hospital
Taipei, Taiwan, 114